SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-175515
Filing Date
2015-05-07
Accepted
2015-05-07 06:03:19
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d907246d10q.htm 10-Q 189402
2 EX-31.1 d907246dex311.htm EX-31.1 8513
3 EX-31.2 d907246dex312.htm EX-31.2 8727
4 EX-32 d907246dex32.htm EX-32 3977
  Complete submission text file 0001193125-15-175515.txt   1969735

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pvct-20150331.xml EX-101.INS 170901
6 XBRL TAXONOMY EXTENSION SCHEMA pvct-20150331.xsd EX-101.SCH 29270
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20150331_cal.xml EX-101.CAL 27169
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20150331_def.xml EX-101.DEF 80347
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20150331_lab.xml EX-101.LAB 219862
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20150331_pre.xml EX-101.PRE 138914
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 15839238
SIC: 2834 Pharmaceutical Preparations